Sasan Roayaie

Summary

Affiliation: Mount Sinai School of Medicine
Country: USA

Publications

  1. ncbi request reprint Neoadjuvant therapies for hepatocellular carcinoma before liver transplantation: a critical appraisal
    Patricia M Lopez
    Mount Sinai Liver Cancer Program, Division of Liver Diseases, Mount Sinai School of Medicine, 1425 Madison Avenue, 11F 70, Box 1123, New York, NY 10029, USA
    Liver Transpl 12:1747-54. 2006
  2. doi request reprint Multifocal hepatocellular carcinoma and precancerous lesions in a patient with autoimmune hepatitis-related cirrhosis
    Stephen C Ward
    The Lillian and Henry M Stratton Hans Popper Department of Pathology, The Mount Sinai Medical Center, New York, New York 10029, USA
    Semin Liver Dis 28:123-7. 2008
  3. ncbi request reprint Resection of hepatocellular carcinoma with macroscopic vascular invasion
    Sasan Roayaie
    Mount Sinai Liver Cancer Program, Mount Sinai Medical Center, New York, NY, USA
    Ann Surg Oncol 20:3754-60. 2013
  4. pmc Resection of hepatocellular cancer ≤2 cm: results from two Western centers
    Sasan Roayaie
    Liver Cancer Program, Mount Sinai Medical Center, New York, NY 10029, USA
    Hepatology 57:1426-35. 2013
  5. ncbi request reprint Recurrence of hepatocellular carcinoma after liver transplant: patterns and prognosis
    Sasan Roayaie
    Recanati Miller Transplantation Institute, Department of Medicine, Mount Sinai Medical Center, Mount Sinai NYU Health System, New York, NY 10029, USA
    Liver Transpl 10:534-40. 2004
  6. ncbi request reprint Recurrent hepatitis C after retransplantation: factors affecting graft and patient outcome
    Michal Carmiel-Haggai
    Recanati Miller Transplantation Institute, Mount Sinai Hospital, The Mount Sinai School of Medicine, PO Box 1504, New York, NY 10029 6574, USA
    Liver Transpl 11:1567-73. 2005
  7. ncbi request reprint Combined adult-to-adult living donor right lobe liver transplantation and pancreatoduodenectomy for distal bile duct adenocarcinoma in a patient with primary sclerosing cholangitis
    Giovanni Varotti
    Recanati Miller Transplantation Institute, The Mount Sinai Hospital, New York, NY, USA
    J Am Coll Surg 197:765-9. 2003
  8. pmc Adult living donor liver transplantation for patients with hepatocellular carcinoma: extending UNOS priority criteria
    Gabriel E Gondolesi
    Recanati Miller Transplantation Institutes, The Mount Sinai Hospital, New York, NY 10029, USA
    Ann Surg 239:142-9. 2004
  9. pmc Resection or transplant-listing for solitary hepatitis C-associated hepatocellular carcinoma: an intention-to-treat analysis
    Hiroshi Sogawa
    Recanati Miller Transplantation Institute, Mount Sinai Medical Center, New York, NY 10029, USA
    HPB (Oxford) 15:134-41. 2013
  10. doi request reprint Liver functional reserve estimation: state of the art and relevance to local treatments
    Fotini Manizate
    Department of Surgery, Division of Surgical Oncology, Mount Sinai Medical Center, New York, NY 10029, USA
    Oncology 78:131-4. 2010

Detail Information

Publications54

  1. ncbi request reprint Neoadjuvant therapies for hepatocellular carcinoma before liver transplantation: a critical appraisal
    Patricia M Lopez
    Mount Sinai Liver Cancer Program, Division of Liver Diseases, Mount Sinai School of Medicine, 1425 Madison Avenue, 11F 70, Box 1123, New York, NY 10029, USA
    Liver Transpl 12:1747-54. 2006
  2. doi request reprint Multifocal hepatocellular carcinoma and precancerous lesions in a patient with autoimmune hepatitis-related cirrhosis
    Stephen C Ward
    The Lillian and Henry M Stratton Hans Popper Department of Pathology, The Mount Sinai Medical Center, New York, New York 10029, USA
    Semin Liver Dis 28:123-7. 2008
    ..We believe this to be the first case in the English literature documenting the presence of preneoplastic lesions in an HCV-negative patient with AIH who developed HCC...
  3. ncbi request reprint Resection of hepatocellular carcinoma with macroscopic vascular invasion
    Sasan Roayaie
    Mount Sinai Liver Cancer Program, Mount Sinai Medical Center, New York, NY, USA
    Ann Surg Oncol 20:3754-60. 2013
    ..Survival for Child's A patients with hepatocellular cancer (HCC) and macroscopic vascular invasion (MVI) has been reported as approximately 8.1 months with sorafenib. The role of surgery for these patients remains controversial...
  4. pmc Resection of hepatocellular cancer ≤2 cm: results from two Western centers
    Sasan Roayaie
    Liver Cancer Program, Mount Sinai Medical Center, New York, NY 10029, USA
    Hepatology 57:1426-35. 2013
    ..79; P = 0.031) were independently associated with recurrence. Patients with a single HCC ≤2 cm and platelet count ≥150,000/μL achieved a median survival of 138 months and a 5-year survival rate of 8%, respectively...
  5. ncbi request reprint Recurrence of hepatocellular carcinoma after liver transplant: patterns and prognosis
    Sasan Roayaie
    Recanati Miller Transplantation Institute, Department of Medicine, Mount Sinai Medical Center, Mount Sinai NYU Health System, New York, NY 10029, USA
    Liver Transpl 10:534-40. 2004
    ..Nonetheless, some patients with recurrence can be expected to live for a considerable period of time. Recurrent disease should be treated surgically when possible, because surgery is independently associated with longer survival...
  6. ncbi request reprint Recurrent hepatitis C after retransplantation: factors affecting graft and patient outcome
    Michal Carmiel-Haggai
    Recanati Miller Transplantation Institute, Mount Sinai Hospital, The Mount Sinai School of Medicine, PO Box 1504, New York, NY 10029 6574, USA
    Liver Transpl 11:1567-73. 2005
    ..Patients experiencing early graft failure due to accelerated forms of HCV should not be denied re-LT with the expectation that a similar disease course will occur after re-LT...
  7. ncbi request reprint Combined adult-to-adult living donor right lobe liver transplantation and pancreatoduodenectomy for distal bile duct adenocarcinoma in a patient with primary sclerosing cholangitis
    Giovanni Varotti
    Recanati Miller Transplantation Institute, The Mount Sinai Hospital, New York, NY, USA
    J Am Coll Surg 197:765-9. 2003
    ..Approximately 20% to 30% of cholangiocarcinomas are localized in the distal bile duct. Pancreatoduodenectomy is the curative therapy for cholangiocarcinomas in this location...
  8. pmc Adult living donor liver transplantation for patients with hepatocellular carcinoma: extending UNOS priority criteria
    Gabriel E Gondolesi
    Recanati Miller Transplantation Institutes, The Mount Sinai Hospital, New York, NY 10029, USA
    Ann Surg 239:142-9. 2004
    ..LDLT allows timely transplantation in patients with early or with large HCC...
  9. pmc Resection or transplant-listing for solitary hepatitis C-associated hepatocellular carcinoma: an intention-to-treat analysis
    Hiroshi Sogawa
    Recanati Miller Transplantation Institute, Mount Sinai Medical Center, New York, NY 10029, USA
    HPB (Oxford) 15:134-41. 2013
    ..This study was conducted to provide a retrospective intention-to-treat comparison of these two curative therapies...
  10. doi request reprint Liver functional reserve estimation: state of the art and relevance to local treatments
    Fotini Manizate
    Department of Surgery, Division of Surgical Oncology, Mount Sinai Medical Center, New York, NY 10029, USA
    Oncology 78:131-4. 2010
    ..Preoperative portal vein embolization is a strategy that can evoke 'regeneration' in anticipation of surgery, serving as a 'stress test' of the liver's regenerative capacity...
  11. pmc Ras pathway activation in hepatocellular carcinoma and anti-tumoral effect of combined sorafenib and rapamycin in vivo
    Pippa Newell
    Mount Sinai Liver Cancer Program, Mount Sinai School of Medicine, 1425 Madison Avenue, New York, NY 10029, USA
    J Hepatol 51:725-33. 2009
    ..We investigated the molecular alterations of the Ras pathway in HCC and the antineoplastic effects of sorafenib in combination with rapamycin, an inhibitor of mTOR pathway, in experimental models...
  12. ncbi request reprint Genome-wide molecular profiles of HCV-induced dysplasia and hepatocellular carcinoma
    Elisa Wurmbach
    Mount Sinai Liver Cancer Program, Division of Hematology Oncology, Department of Medicine, Mount Sinai School of Medicine, New York, NY 10029, USA
    Hepatology 45:938-47. 2007
    ....
  13. pmc MicroRNA-based classification of hepatocellular carcinoma and oncogenic role of miR-517a
    Sara Toffanin
    Mount Sinai Liver Cancer Program, Division of Liver Diseases, Department of Medicine, Tisch Cancer Institute, New York, New York, USA
    Gastroenterology 140:1618-28.e16. 2011
    ..MicroRNAs (miRNAs) are involved in HCC pathogenesis, and their expression profiles have been used to classify cancers. We analyzed miRNA expression in human HCC samples to identify molecular subclasses and oncogenic miRNAs...
  14. ncbi request reprint Marked Differences in acute cellular rejection rates between living-donor and deceased-donor liver transplant recipients
    Lawrence U Liu
    Recanati Miller Transplantation Institute, The Mount Sinai Medical Center, New York, NY 10029, USA
    Transplantation 80:1072-80. 2005
    ..The aims of this study were to compare the incidence of ACR between recipients of live- and deceased-donor liver transplants, and to note any differences in ACR among related and unrelated living-donor recipients...
  15. doi request reprint Hepatic resection for primary hepatolithiasis: a single-center Western experience
    Parissa Tabrizian
    Mount Sinai Liver Cancer Program, Mount Sinai School of Medicine, New York, NY 10029, USA
    J Am Coll Surg 215:622-6. 2012
    ..We analyzed the outcomes of patients undergoing hepatic resection (HR) for PHL at a single Western center...
  16. ncbi request reprint Diaphragmatic hernia after hepatic resection: case series at a single Western institution
    Parissa Tabrizian
    Mount Sinai Medical Center, New York, NY, USA
    J Gastrointest Surg 16:1910-4. 2012
    ..Diaphragmatic hernia (DH) after hepatic resection (HR) is a rare and not well-described complication. We report our experience with DH following a high volume of HRs in a tertiary center...
  17. pmc Gene-expression signature of vascular invasion in hepatocellular carcinoma
    Beatriz Minguez
    Mount Sinai Liver Cancer Program, Division of Liver Diseases, Department of Medicine, Surgical Oncology, Department of Surgery, Department of Pathology, Department of Preventive Medicine, Mount Sinai School of Medicine, New York, NY 10029, USA
    J Hepatol 55:1325-31. 2011
    ..While macroscopic vascular invasion can be detected by radiological techniques, pre-operative detection of microscopic vascular invasion, which complicates 30-40% of patients with early tumors, remains elusive...
  18. pmc A system of classifying microvascular invasion to predict outcome after resection in patients with hepatocellular carcinoma
    Sasan Roayaie
    Mount Sinai Liver Cancer Program, Mount Sinai School of Medicine, New York, New York 10029, USA
    Gastroenterology 137:850-5. 2009
    ..We examined a large cohort of patients with HCC who were treated by resection to identify features of mVI that correlated with recurrence and survival...
  19. pmc Liver transplantation for hepatocellular carcinoma: extension of indications based on molecular markers
    Myron Schwartz
    Mount Sinai Liver Cancer Program, Department of Surgery, Recanati Miller Transplantation Institute, Division of Liver Disease, New York, NY 10029, USA
    J Hepatol 49:581-8. 2008
    ..This study uses molecular data to identify a subgroup of patients who, despite having hepatocellular carcinoma beyond Milan criteria, have favorable outcomes...
  20. doi request reprint A two-step right hepatic lobectomy with portal vein ligation for large hepatocellular carcinoma: rapid induction of left-lobe regeneration and clinicopathologic correlation
    Xianzhong Ding
    The Lillian Henry Stratton Hans Popper Department of Pathology, The Mount Sinai Medical Center, New York, NY 10029 6574, USA
    Semin Liver Dis 33:293-7. 2013
    ..The increased risk of morbidity and mortality certainly must be weighed when contemplating this approach and is discussed in this report. ..
  21. doi request reprint Fifteen-year, single-center experience with the surgical management of intrahepatic cholangiocarcinoma: operative results and long-term outcome
    Manousos M Konstadoulakis
    Recanati Miller Transplantation Institute, Mount Sinai Medical Center, New York, NY, USA
    Surgery 143:366-74. 2008
    ..In the current report, we present our experience with the surgical management of ICC, analyze operative results, and investigate prognostic factors in resected patients...
  22. ncbi request reprint Liver transplantation for neuroendocrine tumors
    Sander Florman
    Recanati Miller Transplantation Institute, The Mount Sinai School of Medicine, New York, New York, USA
    J Gastrointest Surg 8:208-12. 2004
    ..Of the three patients surviving more than 5 years, only one was disease free. In carefully selected patients with metastatic NETs, liver transplantation may be an appropriate option...
  23. doi request reprint Does anatomic versus nonanatomic resection affect recurrence and survival in patients undergoing surgery for colorectal liver metastasis?
    Umut Sarpel
    Department of Surgery, New York University Medical Center, New York, USA
    Ann Surg Oncol 16:379-84. 2009
    ..An emphasis on the preservation of hepatic parenchyma may be of increasing importance in the setting of chemotherapy-associated steatohepatitis, and the growing number of patients undergoing repeated metastasectomy...
  24. ncbi request reprint Strategies for the management of hepatocellular carcinoma
    Myron Schwartz
    Mount Sinai School of Medicine, New York, NY 10029, USA
    Nat Clin Pract Oncol 4:424-32. 2007
    ..There is a need for more effective adjuvant therapies after resection and liver transplantation; newer antiangiogenic agents offer hope for improved outcomes in the future...
  25. ncbi request reprint De novo hepatocellular carcinoma occurring in a transplanted liver: case report and review of the literature
    Anca Croitoru
    The Lillian and Henry M Stratton Hans Popper Department of Pathology, The Mount Sinai Medical Center, One Gustave L Levy Place, New York, New York 10029, USA
    Dig Dis Sci 51:1780-2. 2006
  26. ncbi request reprint Post-liver transplant acute renal failure: factors predicting development of end-stage renal disease
    Anil S Paramesh
    The Recanat Miller Transplantation Institute, The Mount Sinai School of Medicine, New York, NY 10029 6574, USA
    Clin Transplant 18:94-9. 2004
    ..The aim of this study was to determine factors that might predict the development of end stage renal disease (ESRD) in patients who had ARF after OLT...
  27. doi request reprint Resection of hepatocellular carcinoma without cirrhosis
    Brian Shrager
    Mount Sinai Liver Cancer Program, Mount Sinai Medical Center, New York, NY 10029, USA
    Ann Surg 255:1135-43. 2012
    ..The aim of this study was to examine the features and outcomes of noncirrhotic patients undergoing resection for hepatocellular carcinoma...
  28. ncbi request reprint Liver transplantation for hepatocellular carcinoma: is expansion of criteria justified?
    Sasan Roayaie
    Division of Liver Diseases and Recanati Miller Transplantation Institute, Mount Sinai School of Medicine, New York, NY 10029, USA
    Clin Liver Dis 9:315-28. 2005
    ..It is estimated that by the year 2010, the number of patients with HCC awaiting liver transplant in the United States will outnumber the supply of cadaver organs...
  29. doi request reprint Feasibility and preliminary accuracy of high-resolution imaging of the liver and pancreas using FNA compatible microendoscopy (with video)
    Renu Regunathan
    Department of Medicine, Columbia University, New York, New York, USA
    Gastrointest Endosc 76:293-300. 2012
    ..EUS-guided FNA is one of the few techniques that can obtain cells and tissue from the liver and pancreas. However, the technique remains vulnerable to poor specimen quality and sampling error...
  30. ncbi request reprint Surgical resection for advanced gallbladder carcinoma. The Mount Sinai experience
    Manousos M Konstadoulakis
    Recanati Miller Transplantation Institute, Mount Sinai School of Medicine, New York, NY, USA
    Hepatogastroenterology 57:1005-12. 2010
    ..Advanced gallbladder cancer (GC) carries dismal prognosis, due to its extent at diagnosis and the low R0 resection performance rate...
  31. ncbi request reprint FDG PET/CT imaging to rule out extrahepatic metastases before liver transplantation
    Bharat Mocherla
    Division of Nuclear Medicine, Department of Radiology, Mount Sinai School of Medicine, New York, New York 10029 6574, USA
    Clin Nucl Med 32:947-8. 2007
    ..FDG PET/CT imaging revealed multiple FDG-avid pulmonary nodules that were subsequently confirmed to represent Mycobacterium avium intracellular infection on histology...
  32. ncbi request reprint A molecular signature to discriminate dysplastic nodules from early hepatocellular carcinoma in HCV cirrhosis
    Josep M Llovet
    Mount Sinai Liver Cancer Program, Department of Medicine, Mount Sinai School of Medicine, New York 10029, USA
    Gastroenterology 131:1758-67. 2006
    ..Small liver nodules approximately 2 cm are difficult to characterize by radiologic or pathologic examination. Our aim was to identify a molecular signature to diagnose early hepatocellular carcinoma (HCC)...
  33. doi request reprint Hepatocellular carcinoma in chronic hepatitis C in the absence of advanced fibrosis or cirrhosis
    Sara Lewis
    Department of Radiology Body MRI and Translational and Molecular Imaging Institute, Ichan School of Medicine at Mount Sinai, One Gustave Levy Pl, Box 1234, New York, NY 10029, USA
    AJR Am J Roentgenol 200:W610-6. 2013
    ..The objective of our study was to describe the cross-sectional imaging appearance of hepatocellular carcinoma (HCC) in patients with chronic hepatitis C virus (HCV) infection in the absence of advanced fibrosis and cirrhosis...
  34. pmc Long-term results with multimodal adjuvant therapy and liver transplantation for the treatment of hepatocellular carcinomas larger than 5 centimeters
    Sasan Roayaie
    Recanati Miller Transplantation Institute, New York, New York, USA
    Ann Surg 235:533-9. 2002
    ..To determine the long-term results of liver transplantation for hepatocellular carcinoma (HCC) measuring 5 cm or larger treated in a multimodality adjuvant protocol...
  35. doi request reprint Liver functional reserve estimation: state of the art and relevance for local treatments: the Western perspective
    Fotini Manizate
    Department of Surgery, Division of Surgical Oncology, The Mount Sinai Medical Center, 5 East 98th Street, 12th Floor, Box 1259, New York, NY 10029, USA
    J Hepatobiliary Pancreat Sci 17:385-8. 2010
    ..Preoperative portal vein embolization is a strategy that can evoke regeneration in anticipation of surgery, serving as a "stress test" of the liver's regenerative capacity...
  36. ncbi request reprint How should patients with hepatocellular carcinoma recurrence after liver transplantation be treated?
    Myron Schwartz
    Recanati Miller Transplantation Institute, Mount Sinai School of Medicine, New York, USA
    J Hepatol 43:584-9. 2005
  37. pmc Pivotal role of mTOR signaling in hepatocellular carcinoma
    Augusto Villanueva
    Mount Sinai Liver Cancer Program, Division of Liver Diseases, Department of Medicine, Mount Sinai School of Medicine, New York, New York 10029, USA
    Gastroenterology 135:1972-83, 1983.e1-11. 2008
    ..We evaluated mTOR signaling in human HCC, as well as the antitumoral effect of a dual-level blockade of the mTOR pathway...
  38. doi request reprint Second hepatic resection for recurrent hepatocellular cancer: a Western experience
    Sasan Roayaie
    Mount Sinai Liver Cancer Program, Mount Sinai School of Medicine, New York, NY, USA
    J Hepatol 55:346-50. 2011
    ..We analyzed the outcomes of patients undergoing a second hepatic resection for recurrent hepatocellular cancer at a single Western center...
  39. doi request reprint Recurrent pancreatic carcinoma and cholangiocarcinoma: 18F-fluorodeoxyglucose positron emission tomography/computed tomography (PET/CT)
    Katherine Cameron
    Department of Radiology, Mount Sinai Medical Center, New York, NY 10029, USA
    Abdom Imaging 36:463-71. 2011
    ..This article reviews the nature of these carcinomas in the post-therapy setting and describes the strengths and limitations of PET/CT when used for monitoring recurrence...
  40. ncbi request reprint Results of retransplantation for recurrent hepatitis C
    Sasan Roayaie
    Recanati Miller Transplantation Institute, Mount Sinai Hospital of Mount Sinai NYU Health, New York, NY 10029, USA
    Hepatology 38:1428-36. 2003
    ..Candidates for retransplantation with a preoperative PT less than 16 seconds and those receiving grafts from donors younger than 60 years can expect a significantly longer median survival after retransplantation...
  41. ncbi request reprint Hilar cholangiocarcinoma involving the portal vein bifurcation: long-term results after resection
    Luis Munoz
    The Mount Sinai School of Medicine, Recanati Miller Transplantation Institute, New York, NY, USA
    J Hepatobiliary Pancreat Surg 9:237-41. 2002
    ..Portal bifurcation involvement is often thought to contraindicate resection. We reviewed our experience with aggressive surgical management in 28 patients with hilar cholangiocarcinoma...
  42. doi request reprint Revised staging classification improves outcome prediction for small intestinal neuroendocrine tumors
    Michelle Kang Kim
    All authors Mount Sinai School of Medicine, New York, NY
    J Clin Oncol 31:3776-81. 2013
    ..The NET societies have recently proposed a TNM staging classification. In this study, we used population-based data to assess the validity of the staging system...
  43. doi request reprint The role of liver resection at the time of secondary cytoreduction in patients with recurrent ovarian cancer
    Valentin Kolev
    Division of Gynecologic Oncology, Department of Obstetrics, Gynecology, and Reproductive Science, and Division of Hepatobiliary Surgery, Icahn School of Medicine at Mount Sinai, Mount Sinai Medical Center, New York, NY
    Int J Gynecol Cancer 24:70-4. 2014
    ..The aim of this study is to determine the role of liver metastatectomy in the morbidity and survival of patients with recurrent ovarian carcinoma...
  44. pmc Recurrent giant hemangiomas of liver: Report of two rare cases with literature review
    Hongfa Zhu
    Hongfa Zhu, Jie Ouyang, Swan N Thung, The Lillian and Henry M Stratton Hans Popper Department of Pathology, Mount Sinai Medical Center, New York, NY 10029, United States
    World J Gastrointest Surg 4:262-6. 2012
    ..The pathogenesis of tumor progression and recurrence is unknown, as is the management of these patients with recurrent hemangioma, particularly when it is extensive and unresectable...
  45. ncbi request reprint A 48-year-old obese man with a 3 cm liver lesion and a history of hemochromatosis and lymphoma
    Gabriel Levi
    The Lillian and Henry M Stratton Hans Popper Department of Pathology, New York, NY 10029, USA
    Semin Liver Dis 24:327-32. 2004
  46. ncbi request reprint The role of fibrin sealants in hepatic surgery
    Umut Sarpel
    Department of Surgery, Mount Sinai Medical Center, New York, NY, USA
    Surg Technol Int 16:31-6. 2007
    ..This chapter will discuss the basic science foundation of fibrin sealants and their applications in hepatic surgery...
  47. doi request reprint Carcinoma ex microcystic adenoma of the pancreas: a report of a novel form of malignancy in serous neoplasms
    Hongfa Zhu
    Department of Pathology, The Mount Sinai Medical Center, New York, NY 10029, USA
    Am J Surg Pathol 36:305-10. 2012
    ..We believe that this case represents the first case of a cytologically malignant neoplasm arising from a benign serous cystadenoma (carcinoma ex microcystic serous cystadenoma)...
  48. ncbi request reprint Giant hemangioma of the adrenal
    Daniel Silverberg
    Recanati Miller Transplantation Institute, Mount Sinai School of Medicine, New York, NY 10029, USA
    Isr Med Assoc J 6:705-6. 2004
  49. pmc Changing epidemiology of hepatocellular adenoma in the United States: review of the literature
    Charissa Y Chang
    Division of Liver Diseases, The Mount Sinai Medical Center, One Gustave Levy Place, P O Box 1104, New York, NY 10029 6574, USA Recanati Miller Transplant Institute, The Mount Sinai Medical Center, New York, NY, USA
    Int J Hepatol 2013:604860. 2013
    ..This may be a result of newer OCP formulations and increasing prevalence of obesity...
  50. pmc Resection of nonalcoholic steatohepatitis-associated hepatocellular carcinoma: a Western experience
    Brian Shrager
    Division of Surgical Oncology, Department of Surgery, Mount Sinai School of Medicine, One Gustave Levy Place, Box 1259, New York, NY 10029, USA
    Int J Surg Oncol 2012:915128. 2012
    ..Conclusion. Hepatocellular carcinoma may arise in the context of nonalcoholic steatohepatitis, often before cirrhosis has developed. Locally advanced tumors are typical, and long-term failure rate following resection is high...
  51. ncbi request reprint Renal artery thrombosis following secondary cytoreduction in a patient with ovarian cancer
    Konstantin Zakashansky
    Division of Gynecologic Oncology, Department of Obstetrics, Gynecology and Reproductive Science, Mount Sinai Medical Center, 1176 Fifth Avenue, Box 1173, New York, NY 10029 6574, USA
    Gynecol Oncol 105:536-8. 2007
    ..In order to successfully perform aggressive cytoreductive surgery for patients with recurrent epithelial ovarian cancer, resection of retroperitoneal disease in close proximity to major vessels is often required...
  52. pmc Focal gains of VEGFA and molecular classification of hepatocellular carcinoma
    Derek Y Chiang
    Department of Medical Oncology and Center for Cancer Genome Discovery, Dana Farber Cancer Institute, Boston, MA 02115, USA
    Cancer Res 68:6779-88. 2008
    ..Furthermore, the prevalence of VEGFA high-level gains in multiple tumor types suggests indications for clinical trials of antiangiogenic therapies...
  53. ncbi request reprint Recurrence of hepatocellular carcinoma after liver transplantation: is immunosuppression a factor?
    Myron Schwartz
    Liver Transpl 11:494-6. 2005
  54. doi request reprint Aggressive surgical resection for hilar cholangiocarcinoma: is it justified? Audit of a single center's experience
    Manousos M Konstadoulakis
    Recanati Miller Transplantation Institute, Hippocration Hospital of Athens, Athens Medical School, Athens, Greece
    Am J Surg 196:160-9. 2008
    ..The current study presents our experience with resectional surgery for patients with hilar cholangiocarcinoma (HC)...